Silicon Valley-based EBR Systems, a medical device company focused on developing and bringing to market devices to treat patients with certain types of heart failure, has raised A$110m (US$79.33m) and listed shares on ASX. The offer comprises the issue of 101,851,851 shares at an issue price of $1.08 per CDI. One CDI represents one share…
Home Healthcare Markets International Business Australia: EBR Systems raises A$110m and lists IPO on ASX